GSK invested $100 million to expand long-term vaccine manufacturing capabilities in Hamilton
On Apr. 24, 2019, GSK announced $100 million of new investment in its manufacturing site in Hamilton, Montana…
Sinovac announced positive results from phase III trial of a Sabin strain-based inactivated Polio vaccine (sIPV) were published
On Apr. 16, 2019, Sinovac Biotech announced that the positive results from the Company’s Phase III clinical study…
Biotechnology | FDA | Infectious Disease | Polio | Vaccine
FDA approved Vaxelis, a new combination DTaP-IPV-Hib-HepB vaccine for use in children 6 wks-4 yrs of age
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
Seqirus’ Next Generation Cell-based Influenza Vaccine Shows Significantly Greater Effectiveness Compared to Standard Egg-based Options in the 2017-18 US Influenza Season
On Dec. 5, 2018, Seqirus, a CSL subsidiary, announced real-world data showing that its cell-based quadrivalent influenza vaccine…
Genomic analysis offered insight into 2018 Nigeria Lassa fever outbreak
On Oct. 18, 2018, an international team of researchers reported that a surge in Lassa fever cases in…
The American College of Obstetricians and Gynecologists issued a committee opinion on maternal immunization
On Jun. 1, 2018, the American College of Obstetricians and Gynecologists (ACOG) issued a committee opinion on maternal…
WHO recommended use of first typhoid conjugate vaccine
On Apr. 3, 2018, the World Health Organization (WHO) recommended the introduction of typhoid conjugate vaccine (TCV) for…
CDC published updated ACIP recommendations for prevention of hepatitis B virus infection
On Jan. 12, 2018, the U.S. Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory…
Biotechnology | CDC | Diagnostics | FDA | Infectious Disease | Influenza | U.S. Congress | Vaccine | Veterinary
Experts decried lack of flu pandemic readiness, commitment
On Jan. 9, 2018, armed with 1940s-vintage flu vaccine technology and supported by only anemic funding for developing…
Seqirus announced major advances in pandemic preparedness
On Aug. 7, 2017, Seqirus announced that the accelerated development of cell-based manufacturing technology at its state-of-the-art manufacturing…
Biotechnology | Diagnostics | Infectious Disease | Influenza | NIH | Non-Profit Research | Vaccine | Veterinary
HHS Influenza Pandemic Planning Update was published
On Jun. 15, 2017, the U.S. Department of Health and Human Services (HHS) published the nations’s updated Pandemic…
Screwworm eradicated in Florida, again
On April 26, 2017, the U.S. Department of Agriculture’s (USDA) announced that the New World screwworm (NWS) had…
Biotechnology | Disease | Infectious Disease | Influenza | Non-Profit Research | Therapeutics | Vaccine
CDC updated guidelines for use of non-pharmaceutical measures to help prevent spread of pandemic influenza
On Apr. 21, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published updated guidelines for use…
CDC published the 2017 US recommended immunization schedules for 0 through 18 years
On Feb. 10, 2017, the Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Children…
CDC published the 2017 U.S. recommended adult immunization schedule
On Feb. 10, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published the 2017 U.S. recommended…
FDA approved extending the age range for use of FluLaval Quadrivalent to include children 6 to 35 months of age
On Nov. 18, 2016, the U.S. Food and Drug Administration (FDA) approved extending the age range for use…
Artificial Intelligence | Biotechnology | Disease | Genomics | Infectious Disease | Medicine | Non-Profit Research | Therapeutics
Washington University invested $25 million in imaging sciences
On Nov. 18, 2016, Washington University in St. Louis launched a bold, $25 million initiative over the next…
Seqirus received FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
On Aug. 29, 2016, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved AFLURIA® QUADRIVALENT…
CDC published 2016-17 influenza vaccination recommendations
On Aug. 26, 2016, the U.S. Centers for Disease Control and Prevention (CDC) published 2016-17 influenza vaccination recommendations….
Biotechnology | Genomics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Veterinary
Southwest National Primate Research Center at Texas Biomed received $40 million NIH grant
On Aug. 4, 2016, the Southwest National Primate Research Center (SNPRC) at Texas Biomedical Research Institute (Texas Biomed)…
ACIP voted that live attenuated influenza vaccine (LAIV) should not be used during the 2016-2017 flu season
On Jun. 22, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
Agriculture | Biotechnology | Infectious Disease | Medicine | Pharmaceutical | Therapeutics | Vaccine
Texas A&M and iBio execute development agreement for plant-produced pharmaceuticals
On Jun. 7, 2016, IBio and the Texas A&M Institute of Infectious Animal Diseases (TAMUS) announced they had…
TEC Edmonton broke ground on newest technology accelerator with Merck Canada
On Sept. 5, 2017, business incubator TEC Edmonton announced a strategic partnership with Merck Canada to provide new…
Biotechnology | Diagnostics | Disease | Infectious Disease | Medicine | Non-Profit Research | Therapeutics
Texas A&M announced $150 million research campus
On May 2, 2016, John Sharp, Chancellor of The Texas A&M University System, unveiled plans to invest $150…
FDA approved Hiberix for full Hib vaccineﾠ series
On Apr. 29, 2016, GlaxoSmithKline Biologicals in Research Triangle Park, North Carolina, received U.S. Food and Drug Administration…
Antimicrobial Resistance Laboratory Network established by U.S. CDC
In 2016, the Centers for Disease Control and Prevention (CDC) announced the establishment of the Antimicrobial Resistance (AR)…
FDA approved new injectable influenza vaccine, Fluad, for use in people age 65 years and older
On Nov. 25, 2015, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved Fluad™ (Influenza…
The first ancient human genome from Africa was sequenced
On Oct. 8, 2015, a research team reported the first ancient human genome sequence from Africa. The genome…
Tu Youyou won a share of the Nobel Prize in Physiology or Medicine for her discoveries concerning a novel therapy against Malaria
On Oct. 5, 2015, Tu Youyou was awarded a half share of the Nobel Prize in Physiology or…
UNMC awarded $12 million grant by the Dept of HHS to establish and co-lead the nation’s National Ebola Training and Education Center
On Jul. 1, 2015, the UNMC/Nebraska Medicine, in collaboration with Emory University in Atlanta and Bellevue Hospital Center…